vs
Side-by-side financial comparison of BITMINE IMMERSION TECHNOLOGIES, INC. (BMNR) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
BITMINE IMMERSION TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($11.0M vs $9.2M, roughly 1.2× Foghorn Therapeutics Inc.). Foghorn Therapeutics Inc. runs the higher net margin — -234.3% vs -34583.9%, a 34349.7% gap on every dollar of revenue. On growth, BITMINE IMMERSION TECHNOLOGIES, INC. posted the faster year-over-year revenue change (627.6% vs 223.8%). Over the past eight quarters, BITMINE IMMERSION TECHNOLOGIES, INC.'s revenue compounded faster (251.9% CAGR vs 35.3%).
Bitmine Immersion Technologies is a tech firm focused on developing and providing professional immersion cooling solutions for high-performance computing scenarios, including cryptocurrency mining rig clusters and data center infrastructure. Its products boost hardware operating efficiency, cut energy consumption for heat control, extend high-power computing equipment lifespan, and help clients reduce long-term operational costs.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
BMNR vs FHTX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.0M | $9.2M |
| Net Profit | $-3.8B | $-21.7M |
| Gross Margin | 87.1% | — |
| Operating Margin | -34784.7% | -258.2% |
| Net Margin | -34583.9% | -234.3% |
| Revenue YoY | 627.6% | 223.8% |
| Net Profit YoY | -330212.5% | -11.1% |
| EPS (diluted) | $-8.40 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $11.0M | — | ||
| Q4 25 | $2.3M | $9.2M | ||
| Q3 25 | — | $8.2M | ||
| Q2 25 | $2.1M | $7.6M | ||
| Q1 25 | $1.5M | $6.0M | ||
| Q4 24 | $1.2M | $2.9M | ||
| Q3 24 | $682.4K | $7.8M | ||
| Q2 24 | $1.2M | $6.9M |
| Q1 26 | $-3.8B | — | ||
| Q4 25 | $-5.2B | $-21.7M | ||
| Q3 25 | — | $-15.8M | ||
| Q2 25 | $-622.8K | $-17.9M | ||
| Q1 25 | $-1.2M | $-18.8M | ||
| Q4 24 | $-974.0K | $-19.5M | ||
| Q3 24 | — | $-19.1M | ||
| Q2 24 | $-654.2K | $-23.0M |
| Q1 26 | 87.1% | — | ||
| Q4 25 | 55.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 23.9% | — | ||
| Q1 25 | 20.1% | — | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | 16.4% | — | ||
| Q2 24 | 18.1% | — |
| Q1 26 | -34784.7% | — | ||
| Q4 25 | -238564.8% | -258.2% | ||
| Q3 25 | — | -226.9% | ||
| Q2 25 | -22.8% | -279.2% | ||
| Q1 25 | -60.2% | -385.0% | ||
| Q4 24 | -73.6% | -840.5% | ||
| Q3 24 | — | -305.5% | ||
| Q2 24 | -43.6% | -386.6% |
| Q1 26 | -34583.9% | — | ||
| Q4 25 | -226955.7% | -234.3% | ||
| Q3 25 | — | -194.4% | ||
| Q2 25 | -30.4% | -237.3% | ||
| Q1 25 | -76.2% | -316.4% | ||
| Q4 24 | -81.1% | -682.9% | ||
| Q3 24 | — | -244.9% | ||
| Q2 24 | -53.4% | -333.6% |
| Q1 26 | $-8.40 | — | ||
| Q4 25 | $-15.98 | $-0.35 | ||
| Q3 25 | — | $-0.25 | ||
| Q2 25 | $-0.31 | $-0.28 | ||
| Q1 25 | $-0.58 | $-0.30 | ||
| Q4 24 | $-1.66 | $-0.23 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | $-0.26 | $-0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $879.6M | $80.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.9B | $-108.5M |
| Total Assets | $9.9B | $198.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $879.6M | — | ||
| Q4 25 | $887.7M | $80.9M | ||
| Q3 25 | — | $89.3M | ||
| Q2 25 | $1.5M | $72.6M | ||
| Q1 25 | $483.0K | $61.0M | ||
| Q4 24 | $797.3K | $55.5M | ||
| Q3 24 | $499.0K | $57.7M | ||
| Q2 24 | — | $138.9M |
| Q1 26 | $9.9B | — | ||
| Q4 25 | $11.3B | $-108.5M | ||
| Q3 25 | — | $-89.7M | ||
| Q2 25 | $2.9M | $-76.7M | ||
| Q1 25 | $2.9M | $-61.7M | ||
| Q4 24 | $3.8M | $-45.5M | ||
| Q3 24 | $4.1M | $-28.3M | ||
| Q2 24 | $4.6M | $-14.3M |
| Q1 26 | $9.9B | — | ||
| Q4 25 | $11.5B | $198.1M | ||
| Q3 25 | — | $205.0M | ||
| Q2 25 | $8.3M | $226.2M | ||
| Q1 25 | $7.5M | $258.7M | ||
| Q4 24 | $7.9M | $284.0M | ||
| Q3 24 | $7.3M | $308.4M | ||
| Q2 24 | $8.2M | $328.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-88.2M | $-22.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-88.2M | — | ||
| Q4 25 | $-228.4M | $-22.3M | ||
| Q3 25 | — | $-18.9M | ||
| Q2 25 | $1.7M | $-21.0M | ||
| Q1 25 | $-215.0K | $-24.0M | ||
| Q4 24 | $-96.0K | $-24.5M | ||
| Q3 24 | $-30.0K | $-21.0M | ||
| Q2 24 | $-42.7K | $-25.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-228.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | $-114.0K | $-25.0M | ||
| Q3 24 | $-106.0K | $-21.3M | ||
| Q2 24 | $-61.3K | $-25.6M |
| Q1 26 | — | — | ||
| Q4 25 | -9975.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | -9.5% | -875.3% | ||
| Q3 24 | -15.5% | -273.0% | ||
| Q2 24 | -5.0% | -371.0% |
| Q1 26 | 0.0% | — | ||
| Q4 25 | 16.4% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 0.5% | ||
| Q4 24 | 1.5% | 16.8% | ||
| Q3 24 | 11.1% | 4.0% | ||
| Q2 24 | 1.5% | 0.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
